Generic Injectables Market is poised to register a CAGR of 12.3% during the forecast period 2022 to 2028.

The rising frequency of chronic illnesses has resulted in investments in generic injectables innovation. The increased popularity of intravenous (IV) or intramascular (IM) medication delivery techniques has stemmed from the desire for quick therapeutic choices. Generic injectables are also becoming more widely acknowledged as less expensive therapies when compared to branded counterparts. These considerations are driving increased generic injectable market acceptance rates.
During the peak of the coronavirus outbreak in India's second wave, there was an extraordinary demand for Remdesivir, an antiviral medicine used to treat patients. Due to Remdesivir's scarcity, firms in the generic injectables market, such as Hetero Medications, an Indian pharmaceutical company and one of the world's leading producers of anti-retroviral drugs, launched Covifor, a generic version of Remdesivir.

Syringes are among the most difficult to examine containers. With the world's largest immunisation campaign in history, the issues posed by syringe inspection become increasingly pertinent when considering the increasing use of injectable medications. These results have resulted in the necessity for advanced inspection techniques to assist producers in dealing with not just the coronavirus pandemic but also a variety of other ailments.

While other containers, such as cartridges, vials, and ampoules, can enter the inspection process independently, syringes are normally transported by conveyor and then flipped upside down. As a result, strong inspection methods are required so that any concealed particles in the funnel can sink down into the liquid, increasing inspection detectability.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Generic Injectables Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Generic Injectables Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Generic Injectables Market:
• Pfizer Inc.
• Novartis AG (Sandoz International GmbH)
• Baxter
• Fresenius SE & Co. KGaA
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Hikma Pharmaceuticals PLC.
• Lupin Ltd.
• Sanofi
• Biocon
(Note: The list of the major players will be updated with the latest market scenario and trends)

Generic Injectables Market Segmentation:
By Product Type
• Large Molecule Injectables:
  o mAb
  o Insulin
  o Others
• Small Molecule Injectables

By Container Type
• Vials
• Ampoules
• Premix
• Prefilled syringes
• Others

By Application
• Oncology
• Infectious diseases
• Cardiology
• Diabetes
• Immunology
• Others

By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Generic Injectables Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Generic Injectables Market By Product Type, By Container Type, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

 Regional Analysis:

The Asia Pacific region is anticipated to lead the market during the forecast period owing to the increased demand of these injectables with the rising incidences of infectious diseases like typhoid, diarrhoea, cholera, malaria and cancers, high insistence for cheaper medical alternatives and a strong presence of key market players in the region. The North America region, on the other hand, is anticipated to proliferate the market during the forecasted timeframe owing to the approval of novel generic injectables and increasing insistence for cheaper biosimilar products along with increased occurrence of lifestyle-oriented diseases.Pfizer Inc. dominates the global market with over one tenth of the overall market share. Currently, the company is preparing the procedure of developing a formula PF-06881894 which is a biosimilar to Neulasta and which can be used by oncology practitioners. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics